View Future GrowthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsEngro 과거 순이익 실적과거 기준 점검 4/6Engro은 연평균 1.4%의 비율로 수입이 증가해 온 반면, Chemicals 산업은 수입이 6.9% 증가했습니다. 매출은 연평균 17.3%의 비율로 증가했습니다. Engro의 자기자본이익률은 16.5%이고 순이익률은 5.9%입니다.핵심 정보1.45%순이익 성장률2.95%주당순이익(EPS) 성장률Chemicals 산업 성장률19.34%매출 성장률17.31%자기자본이익률16.50%순이익률5.94%최근 순이익 업데이트30 Sep 2024최근 과거 실적 업데이트Reported Earnings • Oct 31Third quarter 2024 earnings released: EPS: PK₨9.08 (vs PK₨22.69 in 3Q 2023)Third quarter 2024 results: EPS: PK₨9.08 (down from PK₨22.69 in 3Q 2023). Revenue: PK₨100.1b (down 27% from 3Q 2023). Net income: PK₨4.87b (down 60% from 3Q 2023). Profit margin: 4.9% (down from 8.9% in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 4% per year whereas the company’s share price has increased by 3% per year.Reported Earnings • Aug 24Second quarter 2024 earnings released: PK₨1.14 loss per share (vs PK₨11.03 profit in 2Q 2023)Second quarter 2024 results: PK₨1.14 loss per share (down from PK₨11.03 profit in 2Q 2023). Revenue: PK₨74.6b (down 29% from 2Q 2023). Net loss: PK₨611.0m (down 110% from profit in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.Reported Earnings • Nov 01Third quarter 2023 earnings released: EPS: PK₨22.68 (vs PK₨13.91 in 3Q 2022)Third quarter 2023 results: EPS: PK₨22.68 (up from PK₨13.91 in 3Q 2022). Revenue: PK₨136.8b (up 50% from 3Q 2022). Net income: PK₨12.2b (up 52% from 3Q 2022). Profit margin: 8.9% (up from 8.8% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has fallen by 3% per year.Reported Earnings • Apr 22First quarter 2023 earnings released: EPS: PK₨8.18 (vs PK₨13.84 in 1Q 2022)First quarter 2023 results: EPS: PK₨8.18 (down from PK₨13.84 in 1Q 2022). Revenue: PK₨97.3b (up 10% from 1Q 2022). Net income: PK₨4.65b (down 42% from 1Q 2022). Profit margin: 4.8% (down from 9.0% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 9.8% growth forecast for the Chemicals industry in Asia. Over the last 3 years on average, earnings per share has increased by 1% per year and the company’s share price has also increased by 1% per year.Reported Earnings • Feb 19Full year 2022 earnings released: EPS: PK₨42.23 (vs PK₨48.45 in FY 2021)Full year 2022 results: EPS: PK₨42.23 (down from PK₨48.45 in FY 2021). Revenue: PK₨356.4b (up 14% from FY 2021). Net income: PK₨24.3b (down 13% from FY 2021). Profit margin: 6.8% (down from 9.0% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in Asia. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.Reported Earnings • Oct 21Third quarter 2022 earnings released: EPS: PK₨13.91 (vs PK₨10.62 in 3Q 2021)Third quarter 2022 results: EPS: PK₨13.91 (up from PK₨10.62 in 3Q 2021). Revenue: PK₨91.3b (up 8.3% from 3Q 2021). Net income: PK₨8.02b (up 31% from 3Q 2021). Profit margin: 8.8% (up from 7.3% in 3Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.모든 업데이트 보기Recent updatesValuation Update With 7 Day Price Move • Dec 03Investor sentiment improves as stock rises 19%After last week's 19% share price gain to PK₨380, the stock trades at a trailing P/E ratio of 6.7x. Average trailing P/E is 9x in the Chemicals industry in Pakistan. Total returns to shareholders of 101% over the past three years.Reported Earnings • Oct 31Third quarter 2024 earnings released: EPS: PK₨9.08 (vs PK₨22.69 in 3Q 2023)Third quarter 2024 results: EPS: PK₨9.08 (down from PK₨22.69 in 3Q 2023). Revenue: PK₨100.1b (down 27% from 3Q 2023). Net income: PK₨4.87b (down 60% from 3Q 2023). Profit margin: 4.9% (down from 8.9% in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 4% per year whereas the company’s share price has increased by 3% per year.Price Target Changed • Sep 26Price target decreased by 7.9% to PK₨396Down from PK₨430, the current price target is an average from 5 analysts. New target price is 26% above last closing price of PK₨314. Stock is up 31% over the past year. The company posted earnings per share of PK₨38.60 last year.Reported Earnings • Aug 24Second quarter 2024 earnings released: PK₨1.14 loss per share (vs PK₨11.03 profit in 2Q 2023)Second quarter 2024 results: PK₨1.14 loss per share (down from PK₨11.03 profit in 2Q 2023). Revenue: PK₨74.6b (down 29% from 2Q 2023). Net loss: PK₨611.0m (down 110% from profit in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.New Risk • May 11New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 73% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (73% net debt to equity). Large one-off items impacting financial results.Declared Dividend • Apr 27Fourth quarter dividend reduced to PK₨11.00Dividend of PK₨11.00 is 73% lower than last year. Ex-date: 7th May 2024 Payment date: 30th May 2024 Dividend yield will be 5.1%, which is lower than the industry average of 12%. Sustainability & Growth Dividend is not covered by earnings (124% earnings payout ratio). However, it is well covered by cash flows (34% cash payout ratio). The dividend has increased by an average of 29% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 38% to bring the payout ratio under control, which is more than the 12% EPS growth achieved over the last 5 years.Upcoming Dividend • Apr 08Upcoming dividend of PK₨2.00 per shareEligible shareholders must have bought the stock before 15 April 2024. Payment date: 17 May 2024. Trailing yield: 13%. Lower than top quartile of Pakistani dividend payers (13%). Higher than average of industry peers (10%).New Risk • Mar 12New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 72% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. This is currently the only risk that has been identified for the company.공시 • Feb 01+ 1 more updateEngro Corporation Limited Announces Outgoing CEO, Ghias KhanEngro Corporation Limited announced the outgoing CEO, Mr. Ghias Khan. Mr. Khan is set to continue in his role until the end of his term, ensuring a smooth transition of leadership.Price Target Changed • Jan 08Price target increased by 16% to PK₨404Up from PK₨349, the current price target is an average from 3 analysts. New target price is 28% above last closing price of PK₨315. Stock is up 12% over the past year. The company posted earnings per share of PK₨42.23 last year.Board Change • Jan 06Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 3 highly experienced directors. Independent Director Shabbir Hashmi was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.공시 • Dec 30Engro Corporation Limited Announces the Resignation of Mr. Mazhar A. Hasnani from Its Board of DirectorsEngro Corporation Limited has announced the resignation of Mr. Mazhar A. Hasnani from its Board of Directors, effective December 29, 2023. This departure marks a change in the composition of the board for one of Pakistan's leading conglomerates.Reported Earnings • Nov 01Third quarter 2023 earnings released: EPS: PK₨22.68 (vs PK₨13.91 in 3Q 2022)Third quarter 2023 results: EPS: PK₨22.68 (up from PK₨13.91 in 3Q 2022). Revenue: PK₨136.8b (up 50% from 3Q 2022). Net income: PK₨12.2b (up 52% from 3Q 2022). Profit margin: 8.9% (up from 8.8% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has fallen by 3% per year.Board Change • May 02Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 4 highly experienced directors. Independent Director Dominique Russo was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Upcoming Dividend • Apr 25Upcoming dividend of PK₨40.00 per share at 13% yieldEligible shareholders must have bought the stock before 02 May 2023. Payment date: 25 May 2023. The company is paying out more than 100% of its earnings and cash flow. Trailing yield: 13%. Within top quartile of Pakistani dividend payers (13%). In line with average of industry peers (14%).Reported Earnings • Apr 22First quarter 2023 earnings released: EPS: PK₨8.18 (vs PK₨13.84 in 1Q 2022)First quarter 2023 results: EPS: PK₨8.18 (down from PK₨13.84 in 1Q 2022). Revenue: PK₨97.3b (up 10% from 1Q 2022). Net income: PK₨4.65b (down 42% from 1Q 2022). Profit margin: 4.8% (down from 9.0% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 9.8% growth forecast for the Chemicals industry in Asia. Over the last 3 years on average, earnings per share has increased by 1% per year and the company’s share price has also increased by 1% per year.Upcoming Dividend • Mar 14Upcoming dividend of PK₨1.00 per share at 11% yieldEligible shareholders must have bought the stock before 21 March 2023. Payment date: 20 April 2023. Trailing yield: 11%. Lower than top quartile of Pakistani dividend payers (13%). Lower than average of industry peers (13%).Reported Earnings • Feb 19Full year 2022 earnings released: EPS: PK₨42.23 (vs PK₨48.45 in FY 2021)Full year 2022 results: EPS: PK₨42.23 (down from PK₨48.45 in FY 2021). Revenue: PK₨356.4b (up 14% from FY 2021). Net income: PK₨24.3b (down 13% from FY 2021). Profit margin: 6.8% (down from 9.0% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in Asia. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.Reported Earnings • Oct 21Third quarter 2022 earnings released: EPS: PK₨13.91 (vs PK₨10.62 in 3Q 2021)Third quarter 2022 results: EPS: PK₨13.91 (up from PK₨10.62 in 3Q 2021). Revenue: PK₨91.3b (up 8.3% from 3Q 2021). Net income: PK₨8.02b (up 31% from 3Q 2021). Profit margin: 8.8% (up from 7.3% in 3Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.Buying Opportunity • Sep 14Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 12%. The fair value is estimated to be PK₨290, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 18% over the last 3 years. Earnings per share has grown by 20%.Upcoming Dividend • Mar 09Upcoming dividend of PK₨1.00 per shareEligible shareholders must have bought the stock before 16 March 2022. Payment date: 14 April 2022. Payout ratio is a comfortable 50% and this is well supported by cash flows. Trailing yield: 9.7%. Lower than top quartile of Pakistani dividend payers (11%). Lower than average of industry peers (12%).Upcoming Dividend • Oct 27Upcoming dividend of PK₨5.00 per shareEligible shareholders must have bought the stock before 03 November 2021. Payment date: 26 November 2021. Trailing yield: 9.1%. Lower than top quartile of Pakistani dividend payers (11%). Lower than average of industry peers (11%).Reported Earnings • Oct 26Third quarter 2021 earnings released: EPS PK₨10.62 (vs PK₨16.12 in 3Q 2020)The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: PK₨84.3b (up 12% from 3Q 2020). Net income: PK₨6.12b (down 34% from 3Q 2020). Profit margin: 7.3% (down from 12% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.Upcoming Dividend • Oct 04Upcoming dividend of PK₨7.00 per shareEligible shareholders must have bought the stock before 11 October 2021. Payment date: 04 November 2021. Trailing yield: 9.2%. Lower than top quartile of Pakistani dividend payers (10%). Lower than average of industry peers (11%).Major Estimate Revision • Aug 06Consensus EPS estimates increase to PK₨51.18The consensus outlook for earnings per share (EPS) in 2021 has improved. 2021 revenue forecast increased from PK₨265.1b to PK₨285.1b. EPS estimate increased from PK₨44.25 to PK₨51.18 per share. Net income forecast to shrink 6.0% next year vs 6.0% decline forecast for Chemicals industry in Pakistan. Consensus price target broadly unchanged at PK₨372. Share price was steady at PK₨294 over the past week.Upcoming Dividend • Jun 05Upcoming dividend of PK₨12.00 per shareEligible shareholders must have bought the stock before 11 June 2021. Payment date: 06 July 2021. Trailing yield: 8.2%. Lower than top quartile of Pakistani dividend payers (8.4%). In line with average of industry peers (8.4%).Reported Earnings • Apr 24First quarter 2021 earnings released: EPS PK₨14.47 (vs PK₨5.76 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: PK₨70.9b (up 58% from 1Q 2020). Net income: PK₨8.34b (up 151% from 1Q 2020). Profit margin: 12% (up from 7.4% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.Upcoming Dividend • Apr 10Upcoming dividend of PK₨2.00 per shareEligible shareholders must have bought the stock before 16 April 2021. Payment date: 18 May 2021. Trailing yield: 8.7%. Within top quartile of Pakistani dividend payers (8.7%). In line with average of industry peers (8.6%).Reported Earnings • Apr 04Full year 2020 earnings released: EPS PK₨44.05 (vs PK₨29.22 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: PK₨248.8b (up 10% from FY 2019). Net income: PK₨25.4b (up 51% from FY 2019). Profit margin: 10% (up from 7.5% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.Major Estimate Revision • Mar 02Analysts update estimatesThe 2021 consensus earning per share (EPS) estimate increased from PK₨45.53 to PK₨52.44. No change was made to the revenue estimate which at the last update was PK₨277.2b. Net income is expected to grow by 19% next year compared to 8.9% decline forecast for the Chemicals industry in Pakistan. The consensus price target increased from PK₨364 to PK₨369. Share price stayed mostly flat at PK₨305 over the past week.Reported Earnings • Feb 20Full year 2020 earnings released: EPS PK₨44.06 (vs PK₨28.70 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: PK₨248.8b (up 10% from FY 2019). Net income: PK₨25.4b (up 54% from FY 2019). Profit margin: 10% (up from 7.3% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.Analyst Estimate Surprise Post Earnings • Feb 20Revenue and earnings beat expectationsRevenue exceeded analyst estimates by 2.9%. Earnings per share (EPS) also surpassed analyst estimates by 2.1%. Over the next year, revenue is forecast to grow 7.2%, compared to a 5.0% growth forecast for the Chemicals industry in Pakistan.Is New 90 Day High Low • Feb 12New 90-day low: PK₨302The company is down 1.0% from its price of PK₨305 on 13 November 2020. The Pakistani market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is PK₨93.96 per share.Is New 90 Day High Low • Jan 08New 90-day high: PK₨319The company is up 6.0% from its price of PK₨301 on 09 October 2020. The Pakistani market is up 8.0% over the last 90 days, indicating the company underperformed over that time. However, its price trend is similar to the Chemicals industry, which is also up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is PK₨90.75 per share.Reported Earnings • Nov 06Third quarter 2020 earnings released: EPS PK₨16.12The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: PK₨75.3b (up 20% from 3Q 2019). Net income: PK₨9.29b (up 52% from 3Q 2019). Profit margin: 12% (up from 9.7% in 3Q 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.Analyst Estimate Surprise Post Earnings • Nov 06Revenue beats expectations, earnings disappointRevenue exceeded analyst estimates by 0.4%. Earnings per share (EPS) missed analyst estimates by 22%. Over the next year, revenue is forecast to stay flat compared to a 5.2% decline forecast for the Chemicals industry in Pakistan.Reported Earnings • Oct 24Third quarter earnings releasedOver the last 12 months the company has reported total profits of PK₨22.0b, up 40% from the prior year. Total revenue was PK₨260.9b over the last 12 months, up 27% from the prior year.매출 및 비용 세부 내역Engro가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이KASE:ENGRO 매출, 비용 및 순이익 (PKR Millions)날짜매출순이익일반관리비연구개발비30 Sep 24511,65230,37129,640030 Jun 24514,21627,92530,265031 Mar 24514,71523,11029,703031 Dec 23482,48921,02027,337030 Sep 23337,5437,83223,233030 Jun 23326,13413,42022,711031 Mar 23340,16818,28922,601031 Dec 22356,42824,33221,426030 Sep 22356,74620,16918,623030 Jun 22349,72318,27217,343031 Mar 22329,05427,54716,120031 Dec 21311,58727,91215,478030 Sep 21289,90229,93914,708030 Jun 21280,97433,10815,341031 Mar 21274,71830,33115,441031 Dec 20248,81825,38015,030030 Sep 20260,76922,52415,092030 Jun 20248,15119,34914,848031 Mar 20230,08416,20713,682031 Dec 19225,76516,83314,017030 Sep 19204,41715,68112,801030 Jun 19184,61313,42513,062031 Mar 19178,69112,52413,050031 Dec 18171,56812,70812,931030 Sep 18156,80512,44012,851030 Jun 18148,08411,72111,601031 Mar 18139,54010,69812,205031 Dec 17128,5939,40711,695030 Sep 17170,11670,03517,134030 Jun 17166,01169,32716,795031 Mar 17157,93569,42815,935031 Dec 16157,20869,10715,493030 Sep 16117,68710,3318,304030 Jun 16112,2438,1518,104031 Mar 16124,78510,6378,073031 Dec 15131,81810,6228,265030 Sep 15141,2168,84410,253030 Jun 15161,43010,35111,663031 Mar 15166,4867,57313,204031 Dec 14175,9587,00714,622030 Sep 14169,9936,34014,637030 Jun 14166,0277,06114,217031 Mar 14162,4138,03413,9410양질의 수익: ENGRO는 PKR29.7B 규모의 큰 일회성 손실이 있어 30th September, 2024까지 지난 12개월 재무 결과에 영향을 미쳤습니다.이익 마진 증가: ENGRO의 현재 순 이익률 (5.9%)은 지난해 (2.3%)보다 높습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: ENGRO의 수익은 지난 5년 동안 연평균 1.4% 증가했습니다.성장 가속화: 지난 1년간 ENGRO 의 수익 증가율(287.8%)은 연간 평균(1.4%)을 초과합니다.수익 대 산업: ENGRO의 지난 1년 수익 증가율(287.8%)은 Chemicals 업계의 13.4%를 상회했습니다.자기자본이익률높은 ROE: ENGRO의 자본 수익률(16.5%)은 낮음으로 평가됩니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2025/01/23 21:34종가2025/01/03 00:00수익2024/09/30연간 수익2023/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Engro Corporation Limited는 10명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관null nullAKD ResearchMuhammad JawaidArif Habib LimitedFarid AlianiBMA Capital Management Ltd.7명의 분석가 더 보기
Reported Earnings • Oct 31Third quarter 2024 earnings released: EPS: PK₨9.08 (vs PK₨22.69 in 3Q 2023)Third quarter 2024 results: EPS: PK₨9.08 (down from PK₨22.69 in 3Q 2023). Revenue: PK₨100.1b (down 27% from 3Q 2023). Net income: PK₨4.87b (down 60% from 3Q 2023). Profit margin: 4.9% (down from 8.9% in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 4% per year whereas the company’s share price has increased by 3% per year.
Reported Earnings • Aug 24Second quarter 2024 earnings released: PK₨1.14 loss per share (vs PK₨11.03 profit in 2Q 2023)Second quarter 2024 results: PK₨1.14 loss per share (down from PK₨11.03 profit in 2Q 2023). Revenue: PK₨74.6b (down 29% from 2Q 2023). Net loss: PK₨611.0m (down 110% from profit in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.
Reported Earnings • Nov 01Third quarter 2023 earnings released: EPS: PK₨22.68 (vs PK₨13.91 in 3Q 2022)Third quarter 2023 results: EPS: PK₨22.68 (up from PK₨13.91 in 3Q 2022). Revenue: PK₨136.8b (up 50% from 3Q 2022). Net income: PK₨12.2b (up 52% from 3Q 2022). Profit margin: 8.9% (up from 8.8% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has fallen by 3% per year.
Reported Earnings • Apr 22First quarter 2023 earnings released: EPS: PK₨8.18 (vs PK₨13.84 in 1Q 2022)First quarter 2023 results: EPS: PK₨8.18 (down from PK₨13.84 in 1Q 2022). Revenue: PK₨97.3b (up 10% from 1Q 2022). Net income: PK₨4.65b (down 42% from 1Q 2022). Profit margin: 4.8% (down from 9.0% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 9.8% growth forecast for the Chemicals industry in Asia. Over the last 3 years on average, earnings per share has increased by 1% per year and the company’s share price has also increased by 1% per year.
Reported Earnings • Feb 19Full year 2022 earnings released: EPS: PK₨42.23 (vs PK₨48.45 in FY 2021)Full year 2022 results: EPS: PK₨42.23 (down from PK₨48.45 in FY 2021). Revenue: PK₨356.4b (up 14% from FY 2021). Net income: PK₨24.3b (down 13% from FY 2021). Profit margin: 6.8% (down from 9.0% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in Asia. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
Reported Earnings • Oct 21Third quarter 2022 earnings released: EPS: PK₨13.91 (vs PK₨10.62 in 3Q 2021)Third quarter 2022 results: EPS: PK₨13.91 (up from PK₨10.62 in 3Q 2021). Revenue: PK₨91.3b (up 8.3% from 3Q 2021). Net income: PK₨8.02b (up 31% from 3Q 2021). Profit margin: 8.8% (up from 7.3% in 3Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • Dec 03Investor sentiment improves as stock rises 19%After last week's 19% share price gain to PK₨380, the stock trades at a trailing P/E ratio of 6.7x. Average trailing P/E is 9x in the Chemicals industry in Pakistan. Total returns to shareholders of 101% over the past three years.
Reported Earnings • Oct 31Third quarter 2024 earnings released: EPS: PK₨9.08 (vs PK₨22.69 in 3Q 2023)Third quarter 2024 results: EPS: PK₨9.08 (down from PK₨22.69 in 3Q 2023). Revenue: PK₨100.1b (down 27% from 3Q 2023). Net income: PK₨4.87b (down 60% from 3Q 2023). Profit margin: 4.9% (down from 8.9% in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 4% per year whereas the company’s share price has increased by 3% per year.
Price Target Changed • Sep 26Price target decreased by 7.9% to PK₨396Down from PK₨430, the current price target is an average from 5 analysts. New target price is 26% above last closing price of PK₨314. Stock is up 31% over the past year. The company posted earnings per share of PK₨38.60 last year.
Reported Earnings • Aug 24Second quarter 2024 earnings released: PK₨1.14 loss per share (vs PK₨11.03 profit in 2Q 2023)Second quarter 2024 results: PK₨1.14 loss per share (down from PK₨11.03 profit in 2Q 2023). Revenue: PK₨74.6b (down 29% from 2Q 2023). Net loss: PK₨611.0m (down 110% from profit in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.
New Risk • May 11New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 73% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (73% net debt to equity). Large one-off items impacting financial results.
Declared Dividend • Apr 27Fourth quarter dividend reduced to PK₨11.00Dividend of PK₨11.00 is 73% lower than last year. Ex-date: 7th May 2024 Payment date: 30th May 2024 Dividend yield will be 5.1%, which is lower than the industry average of 12%. Sustainability & Growth Dividend is not covered by earnings (124% earnings payout ratio). However, it is well covered by cash flows (34% cash payout ratio). The dividend has increased by an average of 29% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 38% to bring the payout ratio under control, which is more than the 12% EPS growth achieved over the last 5 years.
Upcoming Dividend • Apr 08Upcoming dividend of PK₨2.00 per shareEligible shareholders must have bought the stock before 15 April 2024. Payment date: 17 May 2024. Trailing yield: 13%. Lower than top quartile of Pakistani dividend payers (13%). Higher than average of industry peers (10%).
New Risk • Mar 12New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 72% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. This is currently the only risk that has been identified for the company.
공시 • Feb 01+ 1 more updateEngro Corporation Limited Announces Outgoing CEO, Ghias KhanEngro Corporation Limited announced the outgoing CEO, Mr. Ghias Khan. Mr. Khan is set to continue in his role until the end of his term, ensuring a smooth transition of leadership.
Price Target Changed • Jan 08Price target increased by 16% to PK₨404Up from PK₨349, the current price target is an average from 3 analysts. New target price is 28% above last closing price of PK₨315. Stock is up 12% over the past year. The company posted earnings per share of PK₨42.23 last year.
Board Change • Jan 06Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 3 highly experienced directors. Independent Director Shabbir Hashmi was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
공시 • Dec 30Engro Corporation Limited Announces the Resignation of Mr. Mazhar A. Hasnani from Its Board of DirectorsEngro Corporation Limited has announced the resignation of Mr. Mazhar A. Hasnani from its Board of Directors, effective December 29, 2023. This departure marks a change in the composition of the board for one of Pakistan's leading conglomerates.
Reported Earnings • Nov 01Third quarter 2023 earnings released: EPS: PK₨22.68 (vs PK₨13.91 in 3Q 2022)Third quarter 2023 results: EPS: PK₨22.68 (up from PK₨13.91 in 3Q 2022). Revenue: PK₨136.8b (up 50% from 3Q 2022). Net income: PK₨12.2b (up 52% from 3Q 2022). Profit margin: 8.9% (up from 8.8% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has fallen by 3% per year.
Board Change • May 02Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 4 highly experienced directors. Independent Director Dominique Russo was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Upcoming Dividend • Apr 25Upcoming dividend of PK₨40.00 per share at 13% yieldEligible shareholders must have bought the stock before 02 May 2023. Payment date: 25 May 2023. The company is paying out more than 100% of its earnings and cash flow. Trailing yield: 13%. Within top quartile of Pakistani dividend payers (13%). In line with average of industry peers (14%).
Reported Earnings • Apr 22First quarter 2023 earnings released: EPS: PK₨8.18 (vs PK₨13.84 in 1Q 2022)First quarter 2023 results: EPS: PK₨8.18 (down from PK₨13.84 in 1Q 2022). Revenue: PK₨97.3b (up 10% from 1Q 2022). Net income: PK₨4.65b (down 42% from 1Q 2022). Profit margin: 4.8% (down from 9.0% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 9.8% growth forecast for the Chemicals industry in Asia. Over the last 3 years on average, earnings per share has increased by 1% per year and the company’s share price has also increased by 1% per year.
Upcoming Dividend • Mar 14Upcoming dividend of PK₨1.00 per share at 11% yieldEligible shareholders must have bought the stock before 21 March 2023. Payment date: 20 April 2023. Trailing yield: 11%. Lower than top quartile of Pakistani dividend payers (13%). Lower than average of industry peers (13%).
Reported Earnings • Feb 19Full year 2022 earnings released: EPS: PK₨42.23 (vs PK₨48.45 in FY 2021)Full year 2022 results: EPS: PK₨42.23 (down from PK₨48.45 in FY 2021). Revenue: PK₨356.4b (up 14% from FY 2021). Net income: PK₨24.3b (down 13% from FY 2021). Profit margin: 6.8% (down from 9.0% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in Asia. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
Reported Earnings • Oct 21Third quarter 2022 earnings released: EPS: PK₨13.91 (vs PK₨10.62 in 3Q 2021)Third quarter 2022 results: EPS: PK₨13.91 (up from PK₨10.62 in 3Q 2021). Revenue: PK₨91.3b (up 8.3% from 3Q 2021). Net income: PK₨8.02b (up 31% from 3Q 2021). Profit margin: 8.8% (up from 7.3% in 3Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.
Buying Opportunity • Sep 14Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 12%. The fair value is estimated to be PK₨290, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 18% over the last 3 years. Earnings per share has grown by 20%.
Upcoming Dividend • Mar 09Upcoming dividend of PK₨1.00 per shareEligible shareholders must have bought the stock before 16 March 2022. Payment date: 14 April 2022. Payout ratio is a comfortable 50% and this is well supported by cash flows. Trailing yield: 9.7%. Lower than top quartile of Pakistani dividend payers (11%). Lower than average of industry peers (12%).
Upcoming Dividend • Oct 27Upcoming dividend of PK₨5.00 per shareEligible shareholders must have bought the stock before 03 November 2021. Payment date: 26 November 2021. Trailing yield: 9.1%. Lower than top quartile of Pakistani dividend payers (11%). Lower than average of industry peers (11%).
Reported Earnings • Oct 26Third quarter 2021 earnings released: EPS PK₨10.62 (vs PK₨16.12 in 3Q 2020)The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: PK₨84.3b (up 12% from 3Q 2020). Net income: PK₨6.12b (down 34% from 3Q 2020). Profit margin: 7.3% (down from 12% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.
Upcoming Dividend • Oct 04Upcoming dividend of PK₨7.00 per shareEligible shareholders must have bought the stock before 11 October 2021. Payment date: 04 November 2021. Trailing yield: 9.2%. Lower than top quartile of Pakistani dividend payers (10%). Lower than average of industry peers (11%).
Major Estimate Revision • Aug 06Consensus EPS estimates increase to PK₨51.18The consensus outlook for earnings per share (EPS) in 2021 has improved. 2021 revenue forecast increased from PK₨265.1b to PK₨285.1b. EPS estimate increased from PK₨44.25 to PK₨51.18 per share. Net income forecast to shrink 6.0% next year vs 6.0% decline forecast for Chemicals industry in Pakistan. Consensus price target broadly unchanged at PK₨372. Share price was steady at PK₨294 over the past week.
Upcoming Dividend • Jun 05Upcoming dividend of PK₨12.00 per shareEligible shareholders must have bought the stock before 11 June 2021. Payment date: 06 July 2021. Trailing yield: 8.2%. Lower than top quartile of Pakistani dividend payers (8.4%). In line with average of industry peers (8.4%).
Reported Earnings • Apr 24First quarter 2021 earnings released: EPS PK₨14.47 (vs PK₨5.76 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: PK₨70.9b (up 58% from 1Q 2020). Net income: PK₨8.34b (up 151% from 1Q 2020). Profit margin: 12% (up from 7.4% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
Upcoming Dividend • Apr 10Upcoming dividend of PK₨2.00 per shareEligible shareholders must have bought the stock before 16 April 2021. Payment date: 18 May 2021. Trailing yield: 8.7%. Within top quartile of Pakistani dividend payers (8.7%). In line with average of industry peers (8.6%).
Reported Earnings • Apr 04Full year 2020 earnings released: EPS PK₨44.05 (vs PK₨29.22 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: PK₨248.8b (up 10% from FY 2019). Net income: PK₨25.4b (up 51% from FY 2019). Profit margin: 10% (up from 7.5% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
Major Estimate Revision • Mar 02Analysts update estimatesThe 2021 consensus earning per share (EPS) estimate increased from PK₨45.53 to PK₨52.44. No change was made to the revenue estimate which at the last update was PK₨277.2b. Net income is expected to grow by 19% next year compared to 8.9% decline forecast for the Chemicals industry in Pakistan. The consensus price target increased from PK₨364 to PK₨369. Share price stayed mostly flat at PK₨305 over the past week.
Reported Earnings • Feb 20Full year 2020 earnings released: EPS PK₨44.06 (vs PK₨28.70 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: PK₨248.8b (up 10% from FY 2019). Net income: PK₨25.4b (up 54% from FY 2019). Profit margin: 10% (up from 7.3% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
Analyst Estimate Surprise Post Earnings • Feb 20Revenue and earnings beat expectationsRevenue exceeded analyst estimates by 2.9%. Earnings per share (EPS) also surpassed analyst estimates by 2.1%. Over the next year, revenue is forecast to grow 7.2%, compared to a 5.0% growth forecast for the Chemicals industry in Pakistan.
Is New 90 Day High Low • Feb 12New 90-day low: PK₨302The company is down 1.0% from its price of PK₨305 on 13 November 2020. The Pakistani market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is PK₨93.96 per share.
Is New 90 Day High Low • Jan 08New 90-day high: PK₨319The company is up 6.0% from its price of PK₨301 on 09 October 2020. The Pakistani market is up 8.0% over the last 90 days, indicating the company underperformed over that time. However, its price trend is similar to the Chemicals industry, which is also up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is PK₨90.75 per share.
Reported Earnings • Nov 06Third quarter 2020 earnings released: EPS PK₨16.12The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: PK₨75.3b (up 20% from 3Q 2019). Net income: PK₨9.29b (up 52% from 3Q 2019). Profit margin: 12% (up from 9.7% in 3Q 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.
Analyst Estimate Surprise Post Earnings • Nov 06Revenue beats expectations, earnings disappointRevenue exceeded analyst estimates by 0.4%. Earnings per share (EPS) missed analyst estimates by 22%. Over the next year, revenue is forecast to stay flat compared to a 5.2% decline forecast for the Chemicals industry in Pakistan.
Reported Earnings • Oct 24Third quarter earnings releasedOver the last 12 months the company has reported total profits of PK₨22.0b, up 40% from the prior year. Total revenue was PK₨260.9b over the last 12 months, up 27% from the prior year.